Enrico J. Richter
Braunschweig, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Protein-dependent CD4+ T cell specialization and CD8+ T cell-driven IL-2 production in HIV.
Journal: iScience
Published: October 21, 2025
Ultra-low level HIV p24 drives immune activation in antiretroviral therapy-treated people living with HIV.
Journal: Communications medicine
Published: May 08, 2025
A longitudinal study on SARS-CoV-2 seroconversion, reinfection and neutralisation spanning several variant waves and vaccination campaigns, Heinsberg, Germany, April 2020 to November 2022.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: June 28, 2024
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients.
Journal: Nature communications
Published: December 22, 2022
Dynamics, outcomes and prerequisites of the first SARS-CoV-2 superspreading event in Germany in February 2020: a cross-sectional epidemiological study.
Journal: BMJ open
Published: April 07, 2022
SARS-CoV-2 in Environmental Samples of Quarantined Households.
Journal: Viruses
Published: March 29, 2022
Reduction of CD8 T Cell Functionality but Not Inhibitory Capacity by Integrase Inhibitors.
Journal: Journal of virology
Published: January 12, 2022
Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help.
Journal: Cell reports
Published: November 11, 2020
Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections.
Journal: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
Published: October 27, 2020
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections.
Journal: Nature communications
Published: June 17, 2020
Last Updated: 09/26/2026